Showing results (11-20 of 70) with videos related to
Sort By:
Pageof 7
Experimental Hematology & Oncology|March 5, 2025
Ibrutinib and acalabrutinib use and risk of incident atrial fibrillation: a propensity-matched analysisJoachim Alexandre, Jonaz Font, Thibault Lenormand, et al.Bulletin Du Cancer|November 5, 2016
[Management of graft failure and erythroblastopenia in patients undergoing allogeneic hematopoietic stem cell transplantation: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Jérôme Cornillon, Flore Sicre de Fontbrune, Sylvain Chantepie, et al.Current Research in Translational Medicine|November 19, 2025
Chimerism in blood after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia: Results from a cohort studyFarah Khemir, Anaïs R Briant, Anne-Claire Gac, et al.Blood|September 3, 2017
Rituximab-based first-line treatment of cGVHD after allogeneic SCT: results of a phase 2 studyFlorent Malard, Myriam Labopin, Ibrahim Yakoub-Agha, et al.Bone Marrow Transplantation|February 10, 2021
Outcomes following hematopoietic stem cell transplantation in patients treated with standard chemotherapy with or without gemtuzumab ozogamicin for acute myeloid leukemiaCécile Pautas, Emmanuel Raffoux, Juliette Lambert, et al.Bulletin Du Cancer|November 28, 2017
[Allogeneic hematopoietic cell transplantation for Hodgkin's disease, mantle cell lymphoma and other rare entities: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Jordan Gauthier, Sylvain Chantepie, Krimo Bouabdallah, et al.Bulletin Du Cancer|November 28, 2017
[Allogeneic haematopoietic cell transplantation for indolent lymphomas: Guidelines from the Francophone Society Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Jordan Gauthier, Sylvain Chantepie, Krimo Bouabdallah, et al.Bulletin Du Cancer|November 28, 2017
[Allogeneic haematopoietic cell transplantation for diffuse large B cell lymphoma: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Jordan Gauthier, Sylvain Chantepie, Krimo Bouabdallah, et al.Bulletin Du Cancer|November 25, 2017
[Use of alternative donors for allogeneic haematopoietic cell transplantation in lymphoid neoplasms: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Jordan Gauthier, Sylvain Chantepie, Krimo Bouabdallah, et al.Haematologica|April 17, 2025
A phase II study of ponatinib for prevention of relapse after allotransplantation in FLT3 internal tandem duplication mutation positive (FLT3-ITD+) acute myeloid leukemia: the PONALLO trialPatrice Chevallier, Anne Thiebaut, Sylvie François, et al.Pageof 7